Candel Therapeutics Announces Late-Breaking Oral Presentation at SITC Annual Meeting with Data on CAN-2409 in Combination with Nivolumab in a Phase 1 Mechanistic Clinical Trial in Patients with High-Grade Glioma
Combination of nivolumab and CAN-2409 delivered during neurosurgery was generally well tolerated with no significant…
G6 Hospitality Signs Development Agreement for New Studio 6 Plus in Marshall, Illinois
ZenaTech Unveils its Proprietary AI Software Suite Designed to Accelerate Land Survey Delivery for Drone as a Service Commercial, Municipal and Infrastructure Clients